Ann: Notice of Annual General Meeting/Proxy Form, page-46

As long as incentives are not linked to the MC

Just issuing further Shares CR Placements result in an immediate higher MC so that's got to be off the table now,,, easy low hanging fruit..

Name change will clear away the legacy of the past , Stop Clock Aston , No communication Wright and FK what Bishop did? wiped from the first Google searches.

As long as Healey isn't delayed as that's the first real test for the new BOD and management.

MT did a great presentation of the Phase I data to market and that provided the rise to the 50c ATH but Buckland is correct that was all set by Richard Mollard and so was the formulation of the Human MPL Tablets including the application for the successful granting of Fight MND funds.

Now the slate has been cleared so its Neurizons , the New BOD and Management Teams legacy from here on in..

Currently the SP is down below the Placement Price of 19c and that placement specifically raised funds for Trialing ,,, amazing how the landscape changes when the kitty is full with $18m?

SOI has climbed as has the pot of options but as long as Neurizon keeps SOI under 600m then there will still be a significant reward upon the sale.

Best of Luck to all Holders NZT

Has the 750,000 Commercial Run of the Trial Medication been completed ?
Has it been delivered to Healey?
Kick off in October to begin recruitment across 70 sites.....
Thought that would be an easy Price Sensitive announcement to show the market the Science is still progressing